Correlation Between Abeona Therapeutics and Acer Therapeutics
Can any of the company-specific risk be diversified away by investing in both Abeona Therapeutics and Acer Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Abeona Therapeutics and Acer Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Abeona Therapeutics and Acer Therapeutics, you can compare the effects of market volatilities on Abeona Therapeutics and Acer Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Abeona Therapeutics with a short position of Acer Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Abeona Therapeutics and Acer Therapeutics.
Diversification Opportunities for Abeona Therapeutics and Acer Therapeutics
0.35 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Abeona and Acer is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding Abeona Therapeutics and Acer Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acer Therapeutics and Abeona Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Abeona Therapeutics are associated (or correlated) with Acer Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acer Therapeutics has no effect on the direction of Abeona Therapeutics i.e., Abeona Therapeutics and Acer Therapeutics go up and down completely randomly.
Pair Corralation between Abeona Therapeutics and Acer Therapeutics
Given the investment horizon of 90 days Abeona Therapeutics is expected to generate 1.91 times less return on investment than Acer Therapeutics. But when comparing it to its historical volatility, Abeona Therapeutics is 1.88 times less risky than Acer Therapeutics. It trades about 0.03 of its potential returns per unit of risk. Acer Therapeutics is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 85.00 in Acer Therapeutics on January 26, 2024 and sell it today you would lose (4.00) from holding Acer Therapeutics or give up 4.71% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 54.62% |
Values | Daily Returns |
Abeona Therapeutics vs. Acer Therapeutics
Performance |
Timeline |
Abeona Therapeutics |
Acer Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Abeona Therapeutics and Acer Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Abeona Therapeutics and Acer Therapeutics
The main advantage of trading using opposite Abeona Therapeutics and Acer Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Abeona Therapeutics position performs unexpectedly, Acer Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acer Therapeutics will offset losses from the drop in Acer Therapeutics' long position.Abeona Therapeutics vs. Reviva Pharmaceuticals Holdings | Abeona Therapeutics vs. Athira PharmaInc | Abeona Therapeutics vs. Fortress Biotech | Abeona Therapeutics vs. ACADIA Pharmaceuticals |
Acer Therapeutics vs. NRx Pharmaceuticals | Acer Therapeutics vs. Pasithea Therapeutics Corp | Acer Therapeutics vs. SAB Biotherapeutics | Acer Therapeutics vs. Lexaria Bioscience Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Complementary Tools
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume |